321 related articles for article (PubMed ID: 33430864)
1. Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China.
Zhao X; Xu L; Jiang L; Tian J; Zhang Y; Wang D; Sun K; Xu B; Zhao W; Hui R; Gao R; Song L; Yuan J
Cardiovasc Diabetol; 2021 Jan; 20(1):16. PubMed ID: 33430864
[TBL] [Abstract][Full Text] [Related]
2. Real-world long-term outcomes based on three therapeutic strategies in very old patients with three-vessel disease.
Yuan D; Jia S; Zhang C; Jiang L; Xu L; Zhang Y; Xu J; Liu R; Xu B; Hui R; Gao R; Gao Z; Song L; Yuan J
BMC Cardiovasc Disord; 2021 Jun; 21(1):316. PubMed ID: 34187370
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
[No Abstract] [Full Text] [Related]
4. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
5. Implications of left atrial volume index in patients with three-vessel coronary disease: A 6.6-year follow-up cohort study.
Liu R; Song L; Zhang C; Jiang L; Tian J; Xu L; Feng X; Wan L; Zhao X; Xu O; Li C; Gao R; Hui R; Zhao W; Yuan J
Chin Med J (Engl); 2024 Feb; 137(4):441-449. PubMed ID: 37262047
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three treatment strategies for patients with triple-vessel coronary disease and left ventricular dysfunction.
Jiang L; Xu L; Song L; Gao Z; Tian J; Sun K; Yu H; Xu B; Song L; Yuan J
J Interv Cardiol; 2018 Jun; 31(3):310-318. PubMed ID: 29468730
[TBL] [Abstract][Full Text] [Related]
7. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Percutaneous Coronary Intervention, Coronary Artery Bypass Grafting and Medical Therapy in Non-ST Elevation Acute Coronary Syndrome Patients With 3-Vessel Disease.
Jia S; Zhang C; Jiang L; Xu L; Tian J; Zhao X; Feng X; Wang D; Zhang Y; Sun K; Xu J; Liu R; Xu B; Zhao W; Hui R; Gao R; Gao Z; Yuan J; Song L
Circ J; 2020 Sep; 84(10):1718-1727. PubMed ID: 32848116
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with reduced ejection fraction.
Bianco V; Kilic A; Mulukutla S; Gleason TG; Kliner D; Allen CC; Habertheuer A; Aranda-Michel E; Humar R; Navid F; Wang Y; Sultan I
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):1022-1031.e5. PubMed ID: 33059935
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
[TBL] [Abstract][Full Text] [Related]
11. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
12. Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study.
Almeida AS; Fuchs SC; Fuchs FC; Silva AG; Lucca MB; Scopel S; Fuchs FD
Vasc Health Risk Manag; 2020; 16():285-297. PubMed ID: 32764949
[TBL] [Abstract][Full Text] [Related]
13. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
[TBL] [Abstract][Full Text] [Related]
14. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
Watanabe H; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Tazaki J; Watanabe H; Natsuaki M; Minatoya K; Hanyu M; Komiya T; Kimura T;
Catheter Cardiovasc Interv; 2020 Jul; 96(1):42-51. PubMed ID: 31389659
[TBL] [Abstract][Full Text] [Related]
16. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
[TBL] [Abstract][Full Text] [Related]
17. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
18. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease.
Mahmoud AN; Elgendy IY; Mentias A; Saad M; Ibrahim W; Mojadidi MK; Nairooz R; Eshtehardi P; David Anderson R; Samady H
Catheter Cardiovasc Interv; 2017 Oct; 90(4):541-552. PubMed ID: 28296170
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]